Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle - Wikidata - awgldk - TriplyDB

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle

http://www.wikidata.org/entity/Q34506119

about

Silodosin inhibits the growth of bladder cancer cells and enhances the cytotoxic activity of cisplatin via ELK1 inactivation.Prostatic α1-adrenoceptors: new concepts of function, regulation, and intracellular signaling.Cellular Response to Titanium Dioxide Nanoparticles in Intestinal Epithelial Caco-2 Cells is Dependent on Endocytosis-Associated Structures and Mediated by EGFR Silodosin inhibits prostate cancer cell growth via ELK1 inactivation and enhances the cytotoxic activity of gemcitabine.Inhibition of smooth muscle force generation by focal adhesion kinase inhibitors in the hyperplastic human prostate.Editorial comment to "Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia".

P2860

Q36309363-A2F5E81A-6EB1-44BF-8D8E-889762BCD999 Q38137877-ED44AE3A-5C78-426A-81EB-C5316AC02D27 Q38708542-71770F77-67C5-4EA7-A6C0-47D21229192E Q38795167-454D9EE6-8D53-4595-86E7-54BE48384D09 Q39154967-6AB218F3-3268-481F-9608-B7D2A102176D Q46089778-E9155A6B-8FF0-4CEE-B242-A448342FD0EE

P2860

Silodosin inhibits noradrenaline-activated transcription factors Elk1 and SRF in human prostate smooth muscle

http://www.wikidata.org/entity/Q34506119

description

2012 nî lūn-bûn

@nan

2012 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2012 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

name

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@ast

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@en

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@nl

type

label

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@ast

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@en

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@nl

prefLabel

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@ast

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@en

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@nl

P1433

Q34506119-51A4A85F-5EB3-4335-BB10-4BEA06AFE06C

P1476

Q34506119-998EE533-B235-49F5-B933-83310E16FEE3

P2093

Q34506119-049E608E-EC38-4AA9-BAD0-347E19DD74B9

Q34506119-0DB2D289-BA6F-428D-8321-12C61DC3EC6B

Q34506119-17F1D6C9-5A75-4BD0-8172-514D286D711C

Q34506119-3EFCB152-1897-456D-AA86-8F9A15CF5820

Q34506119-47ED3BBA-3BEB-494A-AF9B-C22EDFD88CE9

Q34506119-6BF515B1-AED8-44AE-911F-42F91EE550B1

Q34506119-6DA01966-16D8-45F3-AF10-F7811BF653AE

Q34506119-780EC8C6-8F51-4556-9F35-69528F131D65

Q34506119-D6E8EB68-FB1D-4F8A-9314-B8EF5948C6CE

P2860

Q34506119-02B0AB5B-D429-4EEE-9C96-DAC91F0487C6

Q34506119-0400F795-F14D-42B5-9F8C-5FD5C462053C

Q34506119-040F58B0-4455-467A-B18B-609782BB4B05

Q34506119-0AD0C630-01CF-4B5B-8BC5-F0EC3D7D0812

Q34506119-0C265B9B-62D0-4FCB-B094-B639C4760C06

Q34506119-1151C1CE-6798-4CCC-B01A-78962F0030E2

Q34506119-25A59D2A-387B-4FED-B085-FF7C909487DE

Q34506119-48F85AE3-0261-429F-8B43-2C99400341DB

Q34506119-4A90312E-8290-419D-ABA0-449EB8902816

Q34506119-620E98F6-CF48-4F37-BFD1-2DC948F88E46

P304

Q34506119-91B14134-E6C9-4971-A102-903FE3E82ECC

P31

Q34506119-87E82877-BB1B-4B34-AB4A-157652161B1A

P356

Q34506119-DFB97AA4-3681-4C94-82DB-E6E0E89B38C1

P407

Q34506119-E147BE01-7194-4039-A2FC-161E73CBE9CF

P433

Q34506119-6EC82F03-F893-4544-BE52-66CF1DD2A673

P478

Q34506119-7DDB6933-1176-4425-84F5-731BA2328CED

P50

Q34506119-AE1F3CC8-4050-4BC9-AC3C-BF23DE310C2D

Q34506119-E47C7B1A-18CA-446C-8E6B-398D1042D14C

Q34506119-F730936B-93DD-4727-BC48-D3F642345A80

P577

Q34506119-4C0FCC7D-3368-4456-B104-951109C87D6C

P5875

Q34506119-B132B8FD-948A-46E0-A391-89A5BDF18E18

P698

Q34506119-58A55D88-5B48-44B3-94E8-1215AA03D284

P932

Q34506119-782425DE-87B4-4FA8-83A1-09CC7E8C3482

P356

JOURNAL.PONE.0050904

P1433

P1476

Silodosin inhibits noradrenali ...... n human prostate smooth muscle

@en

P2093

Beata Rutz

http://www.w3.org/2001/XMLSchema#string

Christer Beckmann

http://www.w3.org/2001/XMLSchema#string

Christian Gratzke

http://www.w3.org/2001/XMLSchema#string

Claudius Füllhase

http://www.w3.org/2001/XMLSchema#string

Frank Strittmatter

http://www.w3.org/2001/XMLSchema#string

Karl-Erik Andersson

http://www.w3.org/2001/XMLSchema#string

Martin Hennenberg

http://www.w3.org/2001/XMLSchema#string

Petter Hedlund

http://www.w3.org/2001/XMLSchema#string

Raphaela Waidelich

http://www.w3.org/2001/XMLSchema#string

P2860

Alpha 1-adrenoceptor antagonists terazosin and doxazosin induce prostate apoptosis without affecting cell proliferation in patients with benign prostatic hyperplasia

Multiple repressor pathways contribute to phenotypic switching of vascular smooth muscle cells.

Combined effect of terazosin and finasteride on apoptosis, cell proliferation, and transforming growth factor-beta expression in benign prostatic hyperplasia.

The peripheral zone of the prostate is more prone to tumor development than the transitional zone: is the ETS family the key?

GRP receptor-mediated immediate early gene expression and transcription factor Elk-1 activation in prostate cancer cells.

Induction of prostate apoptosis by alpha1-adrenoceptor antagonists: mechanistic significance of the quinazoline component.

Ternary complex factors: prime nuclear targets for mitogen-activated protein kinases.

Alpha1-, alpha2- and beta-adrenoceptors in the urinary bladder, urethra and prostate.

Ets ternary complex transcription factors.

Alpha1-adrenergic receptors and their inhibitors in lower urinary tract symptoms and benign prostatic hyperplasia.

P304

e50904

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1371/JOURNAL.PONE.0050904

http://www.w3.org/2001/XMLSchema#string

P407

P433

11

http://www.w3.org/2001/XMLSchema#string

P478

7

http://www.w3.org/2001/XMLSchema#string

P50

Claudius Füllhase

Francesco Montorsi

Christian G Stief

P577

2012-11-30T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

233889036

http://www.w3.org/2001/XMLSchema#string

P698

23226423

http://www.w3.org/2001/XMLSchema#string

P932

3511420

http://www.w3.org/2001/XMLSchema#string